Medical News

RSS

PecFent receives Positive Opinion from CHMP for treatment of BTCP

Archimedes Pharma, a leading specialty pharma company, today announced that its lead product, PecFent, has received a Positive Opinion from the Committee for Human Medicinal Products, of the European Medicines Agency. The CHMP is recommending PecFent, an innovative fentanyl nasal spray, be authorised for marketing in European Union countries for the treatment of breakthrough cancer pain - sudden, unpredictable episodes of intense pain that occur despite background pain medication.

25 Jun 2010

Research findings suggest possible diagnostic test for ALS

A team led by a Los Angeles Biomedical Research Institute researcher developed a novel approach to efficiently identify disease relevant genes in human complex neurological disorders and demonstrated the effectiveness of this method by applying it to Amyotrophic Lateral Sclerosis, or Lou Gehrig's Disease, according to a new study reported online in the journal, Human Molecular Genetics.

25 Jun 2010

Investment report on Somaxon Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

25 Jun 2010

HHS Secretary to speak about benefits of Affordable Care Act for women

Today, U.S. Secretary of Health and Human Services Secretary Kathleen Sebelius will speak to the National Partnership for Women and Families about how the Affordable Care Act will benefit women.

25 Jun 2010

Scientist at Children Hospital Los Angeles receives NIH grant to research on meningitis

A white blood cell that normally removes bacteria from the bloodstream helps Escherichia coli (E. coli) accumulate in the blood and enter the brain resulting in the deadly infection known as meningitis. Prasadarao V. Nemani, PhD, a scientist at The Saban Research Institute at Children Hospital Los Angeles plans to find out how this happens with a grant of $1.65 million from the National Institutes of Health - National Institute of Neurological Disorders and Strokes.

25 Jun 2010

PMPRB report: Brand-name drug companies in Canada spent only 7.5% of revenues on R&D in 2009

Research and development spending in Canada by brand-name drug companies has dropped to its lowest level in 20 years, according to the latest annual report of the Patented Medicine Prices Review Board.

25 Jun 2010

HQC report presents different aspects of health care delivered in Saskatchewan hospitals

There's been little change over the last three years in how patients rate the care they receive in Saskatchewan hospitals, according to a report released today by the province's Health Quality Council. The report, entitled Quality Insight 2010, presents an overview of aspects of quality of care delivered in hospitals, in the community for people living with certain chronic diseases, and for seniors taking prescription drugs.

25 Jun 2010

PGXL announces new contractual agreement with GH

PGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health, Inc. The agreement makes PGXL a preferred genetic testing lab for GH. The lab will provide molecular diagnostic tests for GH, which will help physicians make therapeutic decisions and facilitate what has come to be known as "personalized medicine."

25 Jun 2010

Researchers uncover association between free radical-mediated reactions and progression of SLE

University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus. Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship. Full findings of the study are available in the July issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

25 Jun 2010

SAMHSA study: Only 6% of substance abuse treatment facilities offer special programs for gays, lesbians

A new study by the Substance Abuse and Mental Health Services Administration reveals that only 777 of 13,688 (6 percent) substance abuse treatment facilities surveyed across the nation offer special programs for gay and lesbian clients.

25 Jun 2010

Neurosurgeons applaud newly-released draft standards for supervision, duty hours of medical residents

The American Association of Neurological Surgeons, American Board of Neurological Surgery, Congress of Neurological Surgeons, and Society of Neurological Surgeons applaud the newly-released draft standards to revise the national requirements for the supervision and duty hours of medical residents.

25 Jun 2010

Thomson Reuters names Mayo Clinic as one of top 10 hospital systems in the country

Mayo Clinic, for the second year in a row, has been a named a top U.S. health system, according to a Thomson Reuters survey that analyzed the quality and efficiency of 255 health systems across the country. Mayo Clinic, as an enterprise organization operating in Arizona, Florida and Minnesota, was ranked among the 10 top performers.

25 Jun 2010

JZP-6 to be reviewed at joint meeting for treatment of fibromyalgia

Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee will review JZP-6 (sodium oxybate) for the treatment of fibromyalgia at a joint meeting on August 20, 2010.

25 Jun 2010

IDRI signs Research Collaboration Agreement with PATH

Two global health non-profit organizations headquartered in Seattle, Washington, the Infectious Disease Research Institute and PATH, have entered into a Research Collaboration Agreement to evaluate novel adjuvants for their ability to enhance the immune response of pandemic influenza vaccines in development. The collaboration supports the goal of PATH's influenza vaccine project to advance the development of promising new influenza vaccines focusing on novel technologies that can be accessible, affordable, and available to people in low-resource countries in a global outbreak.

25 Jun 2010

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

25 Jun 2010

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

The way prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).

25 Jun 2010

Scientists report first preliminary description of bed bug's sialome

With bed bugs reemerging as a nuisance in some parts of the country, scientists are reporting the first preliminary description of the bug's sialome - the saliva proteins that are the secret to Cimex lectularius' ability to suck blood from its human victims and escape to bite again with risking a lethal slap. The findings, which could have medical applications in diagnosing bed bug bites and preventing the itch, appear in ACS' monthly Journal of Proteome Research.

25 Jun 2010

Corgenix Medical issued additional U.S. patent covering AspirinWorks technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has been issued an additional U.S. patent covering its AspirinWorks technology and product line.

25 Jun 2010

Study on effects of resveratrol on metabolism of microcebus murinus

Resveratrol is a natural substance that is widely studied, for its anti-ageing properties among other things. For the first time, work by a team in the "Mécanismes adaptatifs : des organismes aux communautés" Laboratory (CNRS/Muséum National d'Histoire Naturelle) has revealed that this compound reduces weight gain in lemurs. Such findings provide new information regarding the effects of resveratrol on energy metabolism and the control of body mass in primates. They may give a clearer understanding of the factors that govern obesity in humans. This study is published on 22 June 2010 in /BMC Physiology/.

25 Jun 2010

June 2010 independent survey of retirees covered by Medicare

A June 2010 independent survey of 408 retirees covered by Medicare revealed that 90 days after the passage of health care reform legislation 64% are "very" or "somewhat" confident Medicare will be available the rest of their lives, but just 23% have the same confidence it will be here for their children. The survey further revealed that 61% of respondents are "not" confident that Medicare will be here for their children and another 14% are "unsure."

25 Jun 2010

Medical News

PecFent receives Positive Opinion from CHMP for treatment of BTCP

Research findings suggest possible diagnostic test for ALS

Investment report on Somaxon Pharmaceuticals

HHS Secretary to speak about benefits of Affordable Care Act for women

Scientist at Children Hospital Los Angeles receives NIH grant to research on meningitis

PMPRB report: Brand-name drug companies in Canada spent only 7.5% of revenues on R&D in 2009

HQC report presents different aspects of health care delivered in Saskatchewan hospitals

PGXL announces new contractual agreement with GH

Researchers uncover association between free radical-mediated reactions and progression of SLE

SAMHSA study: Only 6% of substance abuse treatment facilities offer special programs for gays, lesbians

Neurosurgeons applaud newly-released draft standards for supervision, duty hours of medical residents

Thomson Reuters names Mayo Clinic as one of top 10 hospital systems in the country

JZP-6 to be reviewed at joint meeting for treatment of fibromyalgia

IDRI signs Research Collaboration Agreement with PATH

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

PARP inhibitors may be effective in men with prostate cancer due to BRCA2 alteration: Researchers

Scientists report first preliminary description of bed bug's sialome

Corgenix Medical issued additional U.S. patent covering AspirinWorks technology

Study on effects of resveratrol on metabolism of microcebus murinus

June 2010 independent survey of retirees covered by Medicare

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News